Parliament Workbench

Petition · PE01108 · Session 3

Petition by Tina McGeever, on behalf of Mike Gray, consider the provision, on the NHS, of cancer treatment drugs, in particular cetuximab, to ensure equity across NHS boards on the appropriateness, effectiveness and availability of such treatments.

Lodged Submitted 7 Jan 2008 Health
Signatures
632
Comments
0
Considered
15 meetings
in the Official Report

What it asks

Petition by Tina McGeever, on behalf of Mike Gray, consider the provision, on the NHS, of cancer treatment drugs, in particular cetuximab, to ensure equity across NHS boards on the appropriateness, effectiveness and availability of such treatments.

Where it was considered

Official Report
  1. 15 Jan 2008
    1 mention
  2. 19 Feb 2008
    Public Petitions Committee
    Current Petitions
    1 mention
  3. 29 Apr 2008
    Public Petitions Committee
    Cancer Treatment Drugs Inquiry
    3 mentions
  4. 20 May 2008
    Public Petitions Committee
    Cancer Treatment Drugs Inquiry
    1 mention
  5. 18 Nov 2008
    Public Petitions Committee
    Current Petitions
    1 mention
  6. 27 Jan 2009
    Public Petitions Committee
    Current Petitions
    1 mention
  7. 19 May 2009
    Public Petitions Committee
    Current Petitions
    1 mention
  8. 23 Sep 2009
    Plenary
    Petitions Process Inquiry
    1 mention
  9. 6 Oct 2009
    Public Petitions Committee
    Current Petitions
    1 mention
  10. 17 Nov 2009
    Public Petitions Committee
    Current Petitions
    1 mention
  11. 2 Mar 2010
    Public Petitions Committee
    Current Petitions
    1 mention
  12. 20 Apr 2010
    Public Petitions Committee
    Current Petitions
    1 mention
  13. 23 Nov 2010
    Public Petitions Committee
    Current Petitions
    1 mention
  14. 23 Feb 2011
    Meeting of the Parliament
    Public Petitions Committee
    1 mention
  15. 8 Mar 2011
    Public Petitions Committee
    Current Petitions
    2 mentions

Signatures by country

No online signatures are recorded for this petition; the total above may include paper signatures.

Comments

No public comments.